US2003175963A1PendingUtilityA1

Platform for the differentiation of cells

Assignee: UNIV MCGILLPriority: Feb 4, 1999Filed: Mar 11, 2003Published: Sep 18, 2003
Est. expiryFeb 4, 2019(expired)· nominal 20-yr term from priority
C12N 2501/58C12N 2501/105A61K 35/12C12N 2506/22A61P 3/10C12N 2501/13C12N 2501/33C12N 5/0676A61P 5/48
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to an in vitro method for islet cell expansion, which comprises the steps of: a) preparing dedifferentiated cells derived from cells in or associated with post-natal islets of Langerhans; b) expanding the dedifferentiated cells; and c) inducing islet cell differentiation the expanded cells of step b) to become insulin-producing cells.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . An in vitro method for producing cells with at least bipotentiality, which comprises the step of: 
 a) inducing cystic formation in cells in or associated with post-natal islets of Langerhans obtained from a patient to obtain a duct-like structure.    
     
     
         2 . A method for the treatment of diabetes mellitus in a patient, which comprises the steps of: 
 a) inducing cystic formation in post-natal islets of Langerhans cells obtained from said patient to obtain a duct-like structure; and    b) introducing said duct-like structure cells in situ in said patient, wherein said cells are expanded in situ to become insulin-producing cells.    
     
     
         3 . A method for the treatment of diabetes mellitus in a patient, which comprises the steps of: 
 a) inducing in vitro cystic formation in post-natal islets of Langerhans cells obtained from said patient to become insulin-producing cells; and    b) introducing said cells of step a) in situ in saidpatient, wherein said cells produce insulin in situ.

Join the waitlist — get patent alerts

Track US2003175963A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.